Posts by: Vanessa Pataia

News

Dr. Reddy’s Laboratories announced the U.S. launch of a generic version of DDAVP (desmopressin acetate), used to control bleeding in people with mild hemophilia A. The generic is available under the name ... Read more

May 1, 2020May 1, 2020

Catalyst Biosciences Awarded EU Patent for Experimental Hemophilia B Therapies

News

Catalyst Biosciences has received a European Union patent for its investigational hemophilia B treatments, including its lead therapy candidate, dalcinonacog alfa (DalcA) and a preclinical gene therapy candidate called CB ... Read more

April 20, 2020April 20, 2020

Esperoct Prevents Bleeding During Major Surgery in Hemophilia A Patients, Trial Shows

News

Treatment with Esperoct (turoctocog alfa pegol) effectively prevents bleeding during and after major surgery in patients with severe hemophilia A, final data from a Phase 3 trial show. The study, “Turoctocog ... Read more

February 28, 2020February 28, 2020

Obesity Likely Factor in Joint Bleeds and Pain in Hemophilia, Experts Say in US Survey

News

Obesity increases the frequency of joint bleeds and degree of pain, and lowers overall life quality of people with hemophilia in the United States, most healthcare providers agreed in an online ... Read more